D2 | Abstract 14
Annual NUTRIM Symposium 18 November 2020
Prevenar vaccination does not increase antibodies against oxLDL or phosphorylcholine in metabolic disease patients
Inês Magro dos Reis1, Tom Houben1, Yvonne Oligschlaeger1, Tim Hendrikx2, 3 Ger Koek4, Marit Westerterp5, Christoph Binder2,3, David Cassiman6, Ronit Shiri-Sverdlov1
1 Department of Molecular Genetics, School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, The Netherlands
2 Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
3 CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
4 Internal Medicine, Division of Gastroenterology and Hepatology, Maastricht University Medical Centre, Maastricht, The Netherlands.
5 Department of Pediatrics, Section Molecular Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
6 Department of Gastroenterology-Hepatology and Metabolic Center, University Hospitals Leuven, Leuven, Belgium
NUTRIM | School of Nutrition and Translational Research in Metabolism
NUTRIM aims to contribute to health maintenance and personalised medicine by unraveling lifestyle and disease-induced derangements in metabolism and by developing targeted nutritional, exercise and drug interventions. This is facilitated by a state of the art research infrastructure and close interaction between scientists, clinicians, master and PhD students.